MedPath

Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study

Completed
Conditions
Tracheal Intubation
Registration Number
NCT02508948
Lead Sponsor
Mayo Clinic
Brief Summary

In order to examine the current endotracheal intubation practice among critically ill patients, a prospective observational multicenter study of adult critically ill patients was conducted from July 2015 to January 2017 involving 20 ICUs. In this study, the primary aim was to describe, through a prospective observational multicenter study, the current intubation practice of adult critically ill patients undergoing endotracheal intubations with a focus on deriving and validating a prediction model for both immediate airway and hemodynamic complications.

Detailed Description

Aim 1: To derive and validate a prediction model for difficult airway (three or more attempts at laryngoscopy to place an endotracheal tube and/or the need for another operator among the critically ill) \[37\].

Aim 2: To derive and validate a prediction model for hemodynamic compromise, i.e., post-intubation hypotension \[defined as a decrease at any point in mean arterial pressure less than 65 mmHg; systolic blood pressure less than 80 mm Hg and/or a reduction in systolic blood pressure of 40% from baseline; or the initiation of, or increase in infusion dosage of, any vasopressor medication (bolus or infusion) during the 30 minute period following intubation\] \[38-39\].

Aim3: To derive and validate a predication model for hypoxemia (decrease in pulse oximetry to oxygen saturation less than 88% during the procedure).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1288
Inclusion Criteria
  • Patient age โ‰ฅ 18 years
  • Surgical and medical intensive care unit adult patients
  • Adult patients requiring endotracheal intubation during the time period of study
Exclusion Criteria
  • Patient age < 18 years
  • Endotracheal intubations performed outside the ICU (in the operating room, in and outside the hospital) are excluded

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of participants with Hypoxemia in the 30 minutes following intubation30 minutes
Number of participants with hypotension in the 30 minutes following intubation30 minutes
Number of participants with unanticipated difficult airway10 minutes

defined by 3 or more attempts or two operators

Secondary Outcome Measures
NameTimeMethod
Mechanical ventilation free days in-hospital28 days or in-hospital
Total days of ICU/hospital length of stay30 days or in-hospital
Number of participants with vital status (dead/alive)30 days or in-hospital
Number of participants with disposition to home, nursing home or long term care facility30 days or in-hospital

Trial Locations

Locations (16)

Detroit Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

University of Oklahoma Health Sciences Center

๐Ÿ‡บ๐Ÿ‡ธ

Oklahoma City, Oklahoma, United States

Geisinger Health System

๐Ÿ‡บ๐Ÿ‡ธ

Danville, Pennsylvania, United States

Corpus Christi Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Corpus Christi, Texas, United States

University of South California

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Cleveland Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

University of Kentucky

๐Ÿ‡บ๐Ÿ‡ธ

Lexington, Kentucky, United States

Creighton University

๐Ÿ‡บ๐Ÿ‡ธ

Omaha, Nebraska, United States

Mayo Clinic, Scottsdale

๐Ÿ‡บ๐Ÿ‡ธ

Scottsdale, Arizona, United States

Memorial Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Modesto, California, United States

Mercy Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Saint Louis, Missouri, United States

Cynthia Callahan,Berkshire Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Pittsfield, Massachusetts, United States

Mayo Clinic, Jacksonville

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Bridgeport Hospital/Yale

๐Ÿ‡บ๐Ÿ‡ธ

Bridgeport, Connecticut, United States

Marshfield Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Marshfield, Wisconsin, United States

Arora Health Care

๐Ÿ‡บ๐Ÿ‡ธ

Milwaukee, Wisconsin, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath